The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-itch Drugs Market Research Report 2024
Synopsis
An antipruritic ointment is a topical medication used to relieve itching (pruritus) of the skin. It works by reducing the sensation of itching and soothing the skin.
Global Anti-itch Drugs market is projected to reach US$ 4620.8 million in 2029, increasing from US$ 3370 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-itch Drugs market research.
The market for anti-itch ointments is expected to grow steadily in the coming years due to several factors. First, the incidence of skin conditions that cause itchiness is increasing worldwide, largely due to environmental factors such as pollution and climate change. Additionally, an aging population is expected to drive demand for anti-itch ointments, as older adults are more likely to develop skin conditions that cause itchiness.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anti-itch Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johnson & Johnson
Bayer
Sanofi
Combe Incorporated
CR SANJIU
Lingrui
Jinyao Pharma
Dinuo Pharma
Huapont
Medimetriks Pharmaceuticals
Taro Pharmaceutical
Teva
Sun Pharmaceutical
Perrigo
Segment by Type
Single Preparation
Compound Ointment
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Anti-itch Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
An antipruritic ointment is a topical medication used to relieve itching (pruritus) of the skin. It works by reducing the sensation of itching and soothing the skin.
Global Anti-itch Drugs market is projected to reach US$ 4620.8 million in 2029, increasing from US$ 3370 million in 2022, with the CAGR of 4.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-itch Drugs market research.
The market for anti-itch ointments is expected to grow steadily in the coming years due to several factors. First, the incidence of skin conditions that cause itchiness is increasing worldwide, largely due to environmental factors such as pollution and climate change. Additionally, an aging population is expected to drive demand for anti-itch ointments, as older adults are more likely to develop skin conditions that cause itchiness.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Anti-itch Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johnson & Johnson
Bayer
Sanofi
Combe Incorporated
CR SANJIU
Lingrui
Jinyao Pharma
Dinuo Pharma
Huapont
Medimetriks Pharmaceuticals
Taro Pharmaceutical
Teva
Sun Pharmaceutical
Perrigo
Segment by Type
Single Preparation
Compound Ointment
Segment by Application
Hospital
Pharmacy
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Anti-itch Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Anti-itch Drugs Market Overview
1.1 Product Overview and Scope of Anti-itch Drugs
1.2 Anti-itch Drugs Segment by Type
1.2.1 Global Anti-itch Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Single Preparation
1.2.3 Compound Ointment
1.3 Anti-itch Drugs Segment by Application
1.3.1 Global Anti-itch Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Anti-itch Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-itch Drugs Revenue 2018-2029
1.4.2 Global Anti-itch Drugs Sales 2018-2029
1.4.3 Global Anti-itch Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Anti-itch Drugs Market Competition by Manufacturers
2.1 Global Anti-itch Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Anti-itch Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Anti-itch Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Anti-itch Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Anti-itch Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-itch Drugs, Product Type & Application
2.7 Anti-itch Drugs Market Competitive Situation and Trends
2.7.1 Anti-itch Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-itch Drugs Players Market Share by Revenue
2.7.3 Global Anti-itch Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-itch Drugs Retrospective Market Scenario by Region
3.1 Global Anti-itch Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Anti-itch Drugs Global Anti-itch Drugs Sales by Region: 2018-2029
3.2.1 Global Anti-itch Drugs Sales by Region: 2018-2023
3.2.2 Global Anti-itch Drugs Sales by Region: 2024-2029
3.3 Global Anti-itch Drugs Global Anti-itch Drugs Revenue by Region: 2018-2029
3.3.1 Global Anti-itch Drugs Revenue by Region: 2018-2023
3.3.2 Global Anti-itch Drugs Revenue by Region: 2024-2029
3.4 North America Anti-itch Drugs Market Facts & Figures by Country
3.4.1 North America Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Anti-itch Drugs Sales by Country (2018-2029)
3.4.3 North America Anti-itch Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-itch Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Anti-itch Drugs Sales by Country (2018-2029)
3.5.3 Europe Anti-itch Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-itch Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Anti-itch Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Anti-itch Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-itch Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Anti-itch Drugs Sales by Country (2018-2029)
3.7.3 Latin America Anti-itch Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-itch Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-itch Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Anti-itch Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Anti-itch Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-itch Drugs Sales by Type (2018-2029)
4.1.1 Global Anti-itch Drugs Sales by Type (2018-2023)
4.1.2 Global Anti-itch Drugs Sales by Type (2024-2029)
4.1.3 Global Anti-itch Drugs Sales Market Share by Type (2018-2029)
4.2 Global Anti-itch Drugs Revenue by Type (2018-2029)
4.2.1 Global Anti-itch Drugs Revenue by Type (2018-2023)
4.2.2 Global Anti-itch Drugs Revenue by Type (2024-2029)
4.2.3 Global Anti-itch Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Anti-itch Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Anti-itch Drugs Sales by Application (2018-2029)
5.1.1 Global Anti-itch Drugs Sales by Application (2018-2023)
5.1.2 Global Anti-itch Drugs Sales by Application (2024-2029)
5.1.3 Global Anti-itch Drugs Sales Market Share by Application (2018-2029)
5.2 Global Anti-itch Drugs Revenue by Application (2018-2029)
5.2.1 Global Anti-itch Drugs Revenue by Application (2018-2023)
5.2.2 Global Anti-itch Drugs Revenue by Application (2024-2029)
5.2.3 Global Anti-itch Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Anti-itch Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson & Johnson Anti-itch Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Anti-itch Drugs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Anti-itch Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Combe Incorporated
6.4.1 Combe Incorporated Corporation Information
6.4.2 Combe Incorporated Description and Business Overview
6.4.3 Combe Incorporated Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Combe Incorporated Anti-itch Drugs Product Portfolio
6.4.5 Combe Incorporated Recent Developments/Updates
6.5 CR SANJIU
6.5.1 CR SANJIU Corporation Information
6.5.2 CR SANJIU Description and Business Overview
6.5.3 CR SANJIU Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CR SANJIU Anti-itch Drugs Product Portfolio
6.5.5 CR SANJIU Recent Developments/Updates
6.6 Lingrui
6.6.1 Lingrui Corporation Information
6.6.2 Lingrui Description and Business Overview
6.6.3 Lingrui Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lingrui Anti-itch Drugs Product Portfolio
6.6.5 Lingrui Recent Developments/Updates
6.7 Jinyao Pharma
6.6.1 Jinyao Pharma Corporation Information
6.6.2 Jinyao Pharma Description and Business Overview
6.6.3 Jinyao Pharma Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jinyao Pharma Anti-itch Drugs Product Portfolio
6.7.5 Jinyao Pharma Recent Developments/Updates
6.8 Dinuo Pharma
6.8.1 Dinuo Pharma Corporation Information
6.8.2 Dinuo Pharma Description and Business Overview
6.8.3 Dinuo Pharma Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dinuo Pharma Anti-itch Drugs Product Portfolio
6.8.5 Dinuo Pharma Recent Developments/Updates
6.9 Huapont
6.9.1 Huapont Corporation Information
6.9.2 Huapont Description and Business Overview
6.9.3 Huapont Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Huapont Anti-itch Drugs Product Portfolio
6.9.5 Huapont Recent Developments/Updates
6.10 Medimetriks Pharmaceuticals
6.10.1 Medimetriks Pharmaceuticals Corporation Information
6.10.2 Medimetriks Pharmaceuticals Description and Business Overview
6.10.3 Medimetriks Pharmaceuticals Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medimetriks Pharmaceuticals Anti-itch Drugs Product Portfolio
6.10.5 Medimetriks Pharmaceuticals Recent Developments/Updates
6.11 Taro Pharmaceutical
6.11.1 Taro Pharmaceutical Corporation Information
6.11.2 Taro Pharmaceutical Anti-itch Drugs Description and Business Overview
6.11.3 Taro Pharmaceutical Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Taro Pharmaceutical Anti-itch Drugs Product Portfolio
6.11.5 Taro Pharmaceutical Recent Developments/Updates
6.12 Teva
6.12.1 Teva Corporation Information
6.12.2 Teva Anti-itch Drugs Description and Business Overview
6.12.3 Teva Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Teva Anti-itch Drugs Product Portfolio
6.12.5 Teva Recent Developments/Updates
6.13 Sun Pharmaceutical
6.13.1 Sun Pharmaceutical Corporation Information
6.13.2 Sun Pharmaceutical Anti-itch Drugs Description and Business Overview
6.13.3 Sun Pharmaceutical Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sun Pharmaceutical Anti-itch Drugs Product Portfolio
6.13.5 Sun Pharmaceutical Recent Developments/Updates
6.14 Perrigo
6.14.1 Perrigo Corporation Information
6.14.2 Perrigo Anti-itch Drugs Description and Business Overview
6.14.3 Perrigo Anti-itch Drugs Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Perrigo Anti-itch Drugs Product Portfolio
6.14.5 Perrigo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-itch Drugs Industry Chain Analysis
7.2 Anti-itch Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-itch Drugs Production Mode & Process
7.4 Anti-itch Drugs Sales and Marketing
7.4.1 Anti-itch Drugs Sales Channels
7.4.2 Anti-itch Drugs Distributors
7.5 Anti-itch Drugs Customers
8 Anti-itch Drugs Market Dynamics
8.1 Anti-itch Drugs Industry Trends
8.2 Anti-itch Drugs Market Drivers
8.3 Anti-itch Drugs Market Challenges
8.4 Anti-itch Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
